Noscapine

Spezifikationen

128-62-1CAS-Nummer

204-899-2EG-Nummer

(3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3H-2-benzofuran-1-oneIUPAC-Name

C22H23NO7Chemische Formel

413.4 g/molMolekulargewicht

noscapine; 128-62-1; NARCOTINE; Tusscapine; Methoxyhydrastine; Terbenol; Coscopin; Narcompren; Narcosine; Vadebex; Noscapalin; Longatin; Opianine; (-)-Narcotine; Narcotin; Narcotussin; Nectadon; Nicolane; Noscapin; Lyobex; Nipaxon; Opianin; Opian; Coscotabs; alpha-Narcotine; Key-tusscapine; Noscapinum; O-Methylnarcotoline; (-)-alpha-narcotine; Narcotinum; NSC-5366; NSC 5366; DTXSID4023385; 8V32U4AOQU; NSC5366; DTXCID303385; (3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-2H,5H,6H,7H,8H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-1,3-dihydro-2-benzofuran-1-one; (3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3H-2-benzofuran-1-one; 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)-isoquinolin-5-yl), (S-(R*,S*))-; Tropfen, Capval; (3S)-6,7-dimethoxy-3-((5R)-4-methoxy-6-methyl-2H,5H,6H,7H,8H-(1,3)dioxolo(4,5-g)isoquinolin-5-yl)-1,3-dihydro-2-benzofuran-1-one; (3S)-6,7-dimethoxy-3-((5R)-4-methoxy-6-methyl-7,8-dihydro-5H-(1,3)dioxolo(4,5-g)isoquinolin-5-yl)-3H-2-benzofuran-1-one; noscapin hydrochloride; prikkelhoest, Librochin; Hydrochloride, Noscapine; camphoscapine (camsilate); RefChem:927938; Embonate, Noscapine Hydrogen; Hydrogen Embonate, Noscapine; R05DA07; (3S)-6,7-Dimethoxy-3-((5R)-4-methoxy-6-methyl-5,6,7,8-tetrahydro(1,3)dioxolo(4,5-g)isoquinolin-5-yl)isobenzofuran-1(3H)-one; 204-899-2; Capval; Narkotin; Noscapal; Noscapina; L-alpha-Narcotine; Longactin; Hederix (free base); Noscopine; (-)-.alpha.-Narcotine; .alpha.-Narcotine; dl-Narcotine; (+/-)-Noscapine; L-.alpha.-Narcotine; (S,R)-Noscapine; MFCD00069316; A4C6WE7BZN; (S)-6,7-dimethoxy-3-((R)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)isobenzofuran-1(3H)-one; Noscapine base; alpha-Gnoscopine; (3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-2-benzofuran-1(3H)-one; 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-((5R)-5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (3S)-rel-; 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (R*,S*)-; C22H23NO7; Narcotine alkaloid; Noskapin; .alpha.-Gnoscopine; Noscapine dl-form; L-alpha-Noscapine; 8-Methoxyhydrastin; Coscopin (VAN); (3S)-6,7-Dimethoxy-3-[(5R)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-2H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-2-benzofuran-1(3H)-one; (3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3H-isobenzofuran-1-one; SMR000059119; (+-)-Noscapine; (-)-.alpha.-Norcotine; (-)-alpha-Norcotine; (+-)-alpha-Narcotine; 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)-, [S-(R*,S*)]-; Noscapinum [INN-Latin]; Noscapina [INN-Spanish]; UNII-A4C6WE7BZN; UNII-8V32U4AOQU; CCRIS 9304; NSC-96350; Noscapine CRS; HSDB 3372; Noscapine [USP:INN:BAN:JAN]; .beta.-Narcotine; (-)-noscapine; NCGC00016388-01; [S-(R*,S*)]-6,7-Dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)-1(3H)-Isobenzofuranone; 08N; 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (S-(R*,S*))-; CAS-128-62-1; Prestwick_959; (-)-a-Narcotine; EINECS 204-899-2; NSC 96350; Noscapine (narcotine); 1-.alpha.-Narcotine; BRN 0099933; Tocris-1697; Narcotine, (+-)-; NOSCAPINE [INN]; NOSCAPINE [JAN]; NOSCAPINE [MI]; NOSCAPINE [HSDB]; Prestwick0_000563; Prestwick1_000563; Prestwick2_000563; Prestwick3_000563; NARCOTINUM [HPUS]; Papaverine EP Impurity A; CBMicro_048259; NOSCAPINE [MART.]; NOSCAPINE [USP-RS]; NOSCAPINE [WHO-DD]; NOSCAPINE [WHO-IP]; SCHEMBL4559; (S,R)-Noscapine, 97%; Lopac0_000840; BSPBio_000346; 4-27-00-06838 (Beilstein Handbook Reference); MLS000069475; MLS001060855; SPBio_002565; Noscapine (JP15/USP/INN); Noscapine (JP18/USP/INN); BPBio1_000382; CHEMBL364713; NOSCAPINE DL-FORM [MI]; NOSCAPINE [EP MONOGRAPH]; NOSCAPINE, (+/-)-; SCHEMBL29365828; CHEBI:73237; GTPL10212; NOSCAPINE [USP MONOGRAPH]; NOSCAPINUM [WHO-IP LATIN]; DTXSID901032089; GLXC-22722; HMS1569B08; HMS2096B08; HMS2269P05; 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-((5R)-5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (3S)-; 6,7-Dimethoxy-3-(4-methoxy-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-2-benzofuran-1(3H)-one, (S-(R*,S*))- #; MSK10431; Phthalide, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-; (+/-)-.ALPHA.-NARCOTINE; Tox21_110413; BBL012344; BDBM50424716; NSC121869; STK054401; Noscapine 1.0 mg/ml in Acetonitrile; AKOS000278036; Tox21_110413_1; CCG-204096; CS-5115; DB06174; FN09246; NSC-121869; SDCCGSBI-0048054.P004; (-)-3-(2-Methyl-6,7-methylendioxy-8-methoxy-1-isochinolyl)-6,7-dimethoxyphthalid; NCGC00023230-02; NCGC00023230-04; NCGC00023230-05; NCGC00023230-07; NCGC00023230-08; NCGC00023230-10; NCGC00023230-13; NCGC00023230-14; NCGC00023230-28; 5-(6,7-Dimethoxyphthalidyl)-5,6,7,8-tetrahydro-4-methoxy-8-methyl-1,3-dioxolo(4,5-g)isoquinoline; AC-20272; AC-33191; HY-13716; L-alpha-2-Methyl-8-methoxy-6,7-methylenedioxy-1-(6,7-dimethoxy-3-phthalidyl)-1,2,3,4-tetrahydroisoquinaline; NCI60_004322; VS-03291; BIM-0048054.P001; NS00117949; C09592; D01036; EN300-24402818; SR-01000075529-6; BRD-K89237706-001-03-8; Q60998699; Noscapine, European Pharmacopoeia (EP) Reference Standard; Noscapine, United States Pharmacopeia (USP) Reference Standard; WLN: T C566 DO FO KN EH & & TJ HO1 K1 J-DT56 BVO DHJ HO1 IO1; (3S)-3-[(5R)-6-methyl-4-(methyloxy)-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-6,7-bis(methyloxy)-2-benzofuran-1(3H)-one; (3S)-6,7-Dimethoxy-3-[(5R)-5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo [4, 5-g]isoquinolin-5-yl] phthalide; (S,R)-Noscapine; (S)-6,7-dimethoxy-3-((R)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)isobenzofuran-1(3H)-one; 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (R*,S*)-(+-)-; 1(3H)-Isobenzofuranone,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)-, [S-(R*,S*)]-; Phthalide,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)-Synonyme